{"filings":[{"id":1525836,"accession_number":"0001213900-26-076349","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-07-08T20:01:28+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints Darcy Bajko as Chief Commercial Officer effective July 31, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Darcy Bajko appointed CCO, start date July 31, 2026; reports to CEO Vince Capone.","Annual base salary $315,000; eligible for target bonus up to 30% of base.","Granted stock options for 150,000 shares vesting annually over three years.","Bajko previously VP Commercialization at MediView XR, driving revenue to $2.2M.","She helped launch three FDA-cleared AR imaging platforms: MediScout, OmnifyXR, XR90."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":777717,"accession_number":"0001213900-26-063486","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-06-01T20:01:42+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FDA De Novo clearance for DeepView System for Burn Indication; commercial distribution authorized in US.","BARDA awarded $31.7M advanced funding to accelerate DeepView System features.","All five director nominees elected; shareholders approved auditor and Hudson Bay share issuance.","First commercial sales expected by Q4 2026 in US (up to 30 devices via BARDA) and international markets.","Outcome Study planned for Q4 2026 with ~286 patients across 12 sites."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":667319,"accession_number":"0001213900-26-061008","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-05-26T20:00:52+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI receives FDA De Novo clearance for DeepView System for burn indication","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA granted De Novo Classification for DeepView System, authorizing commercial distribution in the US.","DeepView is a non-invasive, multispectral imaging device with proprietary AI algorithm to assess burn wound healing.","System provides clinical assessment in ~20-25 seconds, trained on over 340 billion pixels of burn wound image data.","CEO Vincent Capone calls it a 'defining moment' and 'watershed moment' in the company's history.","Development supported in part by BARDA federal contract 75A50123C00049."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96004,"accession_number":"0001213900-26-046405","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Spectral AI formalizes CEO Vincent Capone’s employment with $500k base, bonus, and RSU grant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Annual base salary of $500,000; eligible for annual target bonus up to 100% of base, minimum $250,000.","RSU grant of 200,000 shares (50% vested April 1, 2026; 50% vest April 1, 2027).","Upon change of control, all RSUs vest immediately before closing.","Employment agreement dated April 17, 2026; Capone was previously appointed CEO on February 10, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96003,"accession_number":"0001213900-26-041479","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints David McGuire as CFO, effective May 4, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David McGuire named CFO effective May 4, 2026; reports to CEO Vincent Capone.","Annual base salary $330,000; eligible for annual bonus up to 30% of base.","Receives option to purchase 150,000 common shares, vesting annually over three years.","McGuire previously CAO at Solo Brands and Deputy CFO/CAO at EZCORP; 14 years at EY.","Severance on without-cause termination: 3 months salary continuation and full vesting of options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109498,"accession_number":"0001213900-26-034047","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-03-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Spectral AI Q4 net income $0.6M; FY 2025 revenue $19.7M; guides 2026 revenue ~$18.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 net income $0.6M ($0.02 diluted EPS) vs net loss ($7.7M) in Q4 2024.","FY 2025 net loss narrowed to ($7.6M) from ($15.3M); R&D revenue $19.7M (down from $29.6M).","Cash at Dec 31, 2025 rose to $15.4M from $5.2M at Dec 31, 2024.","Received additional $31.7M BARDA funding; total BARDA contract up to $150M; De Novo 510(k) submitted for DeepView burn indication.","2026 revenue guidance ~$18.5M, primarily from BARDA contract; no material product sales expected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109497,"accession_number":"0001213900-26-032325","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-03-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI awarded $31.7M additional BARDA funding for DeepView System","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BARDA awards $31.7 million in non-dilutive funding to accelerate DeepView System development.","Company commits additional $9.7 million toward total development costs.","Funding supplements existing $54.9M BARDA contract (up to $150M) as FDA decision awaits.","Focus on burn wound imaging, including total body surface area mapping for mass casualty incidents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109496,"accession_number":"0001213900-26-014251","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints Vincent S. Capone as CEO effective Feb 9, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board dissolved Office of the Chairman; Capone previously served as CFO and General Counsel.","Capone has extensive background in law, accounting, finance, and operations; former KPMG, Reed Smith partner.","CEO transition comes as Spectral AI moves toward commercialization of DeepView burn wound assessment system.","FDA submission for DeepView System occurred in June 2025, a key milestone toward U.S. market entry.","Dr. J. Michael DiMaio remains Executive Chairman to ensure strategic continuity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109495,"accession_number":"0001213900-26-011432","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-02-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Spectral AI's Chief Commercial Officer Jeremiah Sparks steps down; 90-day consulting agreement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeremiah Sparks resigned as CCO effective Feb 1, 2026 to pursue other opportunities, no disagreement with company.","Company has begun a national search for Sparks' replacement.","Sparks entered a 90-day consulting agreement at $4,000 per week for transition services.","Sparks will support ongoing projects during the transition period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109494,"accession_number":"0001213900-26-001781","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Colin Bristow resigns from Spectral AI board effective Jan. 5, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Colin Bristow resigned as director effective January 5, 2026.","Resignation not due to any disagreement with the company on operations, policies, or practices.","No replacement has been announced; board composition reduced accordingly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126008,"accession_number":"0001213900-25-102145","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Spectral AI raises $7.6M in offering of common stock, warrants, pre-funded warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 3,065,000 shares at $1.90, plus 4,000,000 warrants ($2.51 exercise) and 935,000 pre-funded warrants ($0.0001).","Gross proceeds ~$7.6M; closed Oct 24, 2025; Northland Securities acted as placement agent (6% fee).","Proceeds for working capital and general corporate purposes; funds DeepView System development and commercial readiness in 2026.","Registration rights agreement requires filing Form S-3 within 10 days; stockholder approval needed for warrant shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142742,"accession_number":"0001213900-25-075636","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Spectral AI Q2 2025 revenue down 32% to $5.1M; net loss widens to $7.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["R&D revenue $5.1M in Q2 2025 vs. $7.5M in Q2 2024 (down 32.0%), reflecting completion of BARDA clinical trials.","Net loss of $(7.9)M in Q2 2025 vs. $(2.9)M in Q2 2024, primarily due to $(5.4)M fair value change in warrant liability.","Cash improved to $10.5M as of June 30, 2025, from $5.2M at Dec 31, 2024, aided by $8.5M debt draw and $2.7M equity.","Submitted De Novo application to FDA in June 2025 for the DeepView System, a key regulatory milestone.","Reiterated FY 2025 revenue guidance of approximately $21.5M, excluding commercial contributions from DeepView."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":11772000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160824,"accession_number":"0001213900-25-059623","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI submits De Novo request to FDA for DeepView burn assessment system","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Spectral AI submitted a De Novo request to the FDA for its DeepView System on June 30, 2025.","DeepView System uses multispectral imaging and AI to assess burn wound healing potential within 7 days of injury.","Due to novel technology with no predicate device, the De Novo regulatory pathway is being pursued.","System trained on over 340 billion clinically validated data points to provide non-healing prediction.","DeepView received Breakthrough Device Designation from FDA in 2018."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160823,"accession_number":"0001213900-25-050760","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-06-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Spectral AI dismisses KPMG as auditor, engages Forvis Mazars for fiscal 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit Committee unanimously voted to dismiss KPMG effective May 29, 2025.","No disagreements with KPMG during fiscal 2023 and 2024.","Previously reported material weaknesses in internal controls noted.","Engaged Forvis Mazars as independent registered public accounting firm for year ending Dec 31, 2025.","KPMG letter concurring with disclosures filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160822,"accession_number":"0001213900-25-049450","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI names Stanley Micek as permanent Chief Operating Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stanley Micek, previously interim COO since May 2024, appointed permanent COO effective May 30, 2025.","Base annual compensation set at $360,000 plus eligibility for discretionary bonus by Board.","Micek leads data science, software, hardware, imaging and systems teams for FDA submission of DeepView System.","Prior to interim COO, Micek was SVP Business Development & Strategy at MiMedx and held roles at Ohio State Univ.","Company focuses on AI-powered wound diagnostics for faster treatment decisions, with initial application in burn care."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160821,"accession_number":"0001213900-25-048888","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-05-29T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Spectral AI shareholders elect all six director nominees and ratify KPMG as auditor at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual meeting held May 28, 2025; 15.55M shares (60.8% of outstanding) represented.","All six director nominees elected: Bristow, Cotton, DiMaio, Mellish, Sadagopan, Snyder.","Colin Bristow elected as new director; all others re-elected from prior term.","Appointment of KPMG LLP as independent auditor for fiscal 2025 ratified with 15.38M for, 164K against.","No other proposals or material events disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160820,"accession_number":"0001213900-25-043277","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-05-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Spectral AI Q1 net income $2.9M; cash $14.1M; FDA De Novo submission planned H1 2025","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 R&D revenue $6.7M (+6% YoY); net income $2.9M vs net loss $(3.2)M in Q1 2024.","Net income largely driven by $4.4M non-cash decrease in warrant liability fair value.","Cash improved to $14.1M at March 31, 2025 from $5.2M at Dec 2024.","Debt financing of $15M from Avenue Capital; initial draw $8.5M; also raised $2.7M equity.","Burn Validation Study completed with 164 patients; FY 2025 revenue guidance reiterated at ~$21.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":6707000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160819,"accession_number":"0001213900-25-027531","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-04-02T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Spectral AI reports FY2024 R&D revenue $29.6M; net loss $(15.3)M; plans FDA submission by Q2 2025","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2024 R&D revenue $29.6M (+63.5% YoY); net loss $(15.3)M ($(0.85)/share) vs $(20.9)M in FY2023.","Burn Validation Study: DeepView sensitivity 86.6% (image-wise) vs 40.8% for burn physicians; FDA De Novo submission planned by Q2 2025.","Cash $5.2M at Dec 31, 2024; raised $11.2M in Q1 2025 via $8.5M debt & $2.7M equity; FY2025 revenue guidance ~$21.5M.","CFO Vincent Capone amended employment: base salary $440k, bonus up to $250k; 100k RSUs vested, 75k stock options granted.","Spin-off of Spectral IP into public company expected by end of Q2 2025; warrants repriced from $11.50 to $2.75."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":6707000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179022,"accession_number":"0001013762-25-002818","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Spectral AI closes $15M debt facility with $2.7M equity raise; $14M cash for DeepView launch","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Debt financing of up to $15M from Avenue Capital Group; initial draw $8.5M, maturity March 2028, interest-only for 15 months.","Equity offering of 2,076,923 shares at $1.30/share plus warrants at $1.80; gross proceeds $2.7M.","Second tranche of $6.5M debt contingent on FDA clearance of DeepView System plus $7M equity raise.","Company has over $14M cash on hand; no additional stock sales for 180 days.","Placement agents: SP Angel (UK) and Dominari Securities (US)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179021,"accession_number":"0001213900-25-024540","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-03-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI DeepView System outperforms burn physicians in validation study; FDA submission planned mid-2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["DeepView sensitivity 86.6% vs burn physicians 40.8% at image-wise level; pixel-wise 81.9% vs 38.8%.","Dice score 68.5% vs 39.2%; specificity 61.2% vs anticipated 36% (CJA 79.1%).","Study enrolled 164 patients (115 adult, 49 pediatric) across U.S. burn centers; one of largest U.S. burn trials.","Plans FDA De Novo submission by Q2 2025; targets clearance early 2026 and rapid commercialization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179020,"accession_number":"0001213900-25-020184","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Spectral AI raises $449,694 in registered direct offering of 270,900 shares at $1.66/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 270,900 shares of common stock at $1.66 per share, gross proceeds $449,694.","Closing occurred December 11, 2024; net proceeds for working capital and general corporate purposes.","Investors have option to purchase additional shares up to $5M (or one-third of public float) at a formula price.","Placement agent SP Angel Corporate Finance LLP received 7% cash fee.","Securities sold under effective S-3 registration statement (File No. 333-282681)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179019,"accession_number":"0001213900-25-020183","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Spectral AI enters $5M registered direct offering with Liqueous LP at $1.38/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 920,000 common shares and pre-funded warrants for 725,000 shares at $1.38 per unit.","Pre-funded warrants exercisable at $0.001 per share, immediately upon issuance.","Aggregate commitment up to $5M; investor has option to buy additional shares up to that amount.","Investor granted right of first refusal on future equity offerings until commitment is satisfied.","Offering priced at at-the-market value; 20% price decline triggers mutual repricing consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179018,"accession_number":"0001213900-25-020182","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Spectral AI enters $5M equity purchase deal with Liqueous LP; initial draw of 500k shares at $1.80","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Securities purchase agreement allows up to $5M in common stock sales to Liqueous LP over six-month commitment period.","On Dec 12, 2024, investor delivered purchase notice for 500,000 shares at $1.80 per share (~$0.9M).","Pricing for additional draws is the lower of prior day close or 5-day VWAP, subject to 4.99% beneficial ownership limit.","Company must maintain sufficient registered shares; late delivery triggers 4% daily penalty up to 10 business days.","Filing dated March 4, 2025, reports agreement entered Nov 18, 2024, and first draw Dec 12, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195702,"accession_number":"0001213900-24-111671","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI regains Nasdaq listing compliance; moot letter received Dec 20","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq 'moot' letter on Dec 20, 2024 confirming compliance with all listing standards.","Hearing regarding continued listing on Nasdaq Capital Market is no longer needed.","Chairman Dr. Michael DiMaio expressed confidence in company's progress and FDA submission."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195701,"accession_number":"0001213900-24-107873","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Spectral AI faces Nasdaq delisting for failing $35M market value rule; hearing requested","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Spectral AI on Dec. 5, 2024 that common stock (MDAI) will be delisted for failing to maintain minimum $35M market value of listed securities by Dec. 2, 2024.","Company timely requested a hearing before Nasdaq Listing Qualifications Panel, which automatically stays delisting pending a final decision.","Spectral AI currently has market capitalization above $35M and believes it can regain compliance within the extended period if granted.","There is no assurance the Panel will grant an extension beyond the 180-day cure period ending December 2, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195700,"accession_number":"0001213900-24-087520","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI CEO Peter Carlson resigns; founder Dr. DiMaio returns as Chairman; Office created","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Peter M. Carlson resigned as CEO and director effective Oct 14, 2024; will serve as consultant for 15 months at $27,500/month.","Dr. J. Michael DiMaio, founder and second largest shareholder, named Chairman of the Board.","Office of the Chairman created; team includes CFO Vincent Capone, CCO Jeremiah Sparks, Interim COO Stan Micek, GM Louis Percoco.","Richard Cotton remains on Board as head of Audit Committee and Lead Independent Director.","Company re-focuses on commercialization, FDA approval, BARDA relationship, and strategic partnerships."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211973,"accession_number":"0001213900-24-068363","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI posts investor deck showing 2024E rev ~$28M (+56% YoY) and 85% burn trial enrollment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["H1 2024 revenue $13.8M; FY 2023 revenue $18M, FY 2024 expected ~$28M.","Cash position $6.9M at June 30, 2024; $10M committed equity facility secured.","Burn pivotal trial 85%+ enrolled (160 goal); enrollment completion expected Sept 2024.","DeepView platform targets burn ($3.7B TAM) and diabetic foot ulcer ($11B TAM) markets.","Joined Russell Microcap Index; 26 issued and 38 pending patents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211972,"accession_number":"0001213900-24-061195","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Spectral AI continues push for Nasdaq probe into alleged naked short selling; cites 40% excess shares on NOBO/OBO list","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board member and largest shareholder Erich Spangenberg leads the inquiry, sending a follow-up letter to Nasdaq on July 15, 2024.","Company states combined NOBO & OBO list as of May 28, 2024, exceeds MDAI float by over 40%, verified with Broadridge.","Letter notes MDAI regularly appears on failure-to-deliver list and alleges naked shorting is prevalent in de-SPAC companies.","Spangenberg requests a meeting with Nasdaq CEO Adena Friedman on July 17-19; prior June 24 letter received no response."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230793,"accession_number":"0001213900-24-055133","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Spectral AI alleges naked short selling inflated float >40%; requests Nasdaq, state probes","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Claims NOBO and OBO lists exceed total public float by over 40%, indicating naked short selling.","Sent letters to Nasdaq and securities regulators in Florida, Texas, Louisiana seeking investigations.","Inquiry led by board member and largest shareholder Erich Spangenberg.","U.S. government has provided over $256 million in funding for Spectral AI's burn wound diagnostics device.","Company states naked shorting violates SEC Regulation SHO and applicable state securities laws."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230792,"accession_number":"0001213900-24-050066","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Spectral AI receives Nasdaq delisting notice for failing $35M market value requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Spectral AI on June 3, 2024, of non-compliance with minimum market value of listed securities ($35M).","Company has 180 calendar days, until December 2, 2024, to regain compliance.","Can cure if market cap closes at or above $35M for 10 consecutive business days during the period.","If not cured, Nasdaq may grant a second 180-day period or begin delisting; appeal rights exist."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230791,"accession_number":"0001213900-24-044245","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Spectral AI expands board to seven, appoints Erich Spangenberg; shareholders approve equity plan and share issuance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board expanded to seven; Erich Spangenberg appointed as director, returning after declining reelection.","Six directors elected: Cotton, Carlson, DiMaio, Mellish, Sadagopan, Snyder for one-year terms.","Shareholders ratified adoption of 2023 Long Term Incentive Plan, replacing 2018 and 2022 plans.","Ratified KPMG LLP as independent auditor for fiscal 2024.","Authorized issuance of up to 6,369,937 shares to YA II PN, Ltd. under Standby Equity Purchase Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230790,"accession_number":"0001213900-24-029307","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Spectral AI COO Dr. Niko Pagoulatos resigns; Stan Micek named interim COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Niko Pagoulatos resigned as COO on March 29, 2024; resignation not due to any disagreement with the Company.","Stan Micek appointed interim COO effective April 8, 2024.","Micek previously served as SVP, Business Development & Strategy at MiMedx Group and CCO at M2Gen Corp.","Mr. Micek has extensive experience in medical technology and commercialization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230789,"accession_number":"0001213900-24-028700","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI names Jeremiah Sparks CCO; base salary $295K plus options","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeremiah Sparks appointed Chief Commercialization Officer effective April 1, 2024.","Sparks previously VP of Global Strategy at AVITA Medical; over 20 years med device marketing.","Compensation: $295,000 base salary, up to 30% bonus, and 30,000 stock options vesting over 3 years.","Sparks to lead domestic and international commercialization of DeepView wound diagnostics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249182,"accession_number":"0001213900-24-027447","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-03-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Spectral AI reports FY2023 net loss of $20.9M ($1.48/sh); guides FY2024 revenue $28M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 R&D revenue $5.3M; FY2023 R&D revenue $18.1M (down from $25.4M YoY).","Net loss FY2023 $20.9M vs $2.9M in FY2022; includes $8.3M non-recurring transaction costs.","Cash $4.8M at Dec 31, 2023; no long-term debt; raised $5M via prepaid advance in Q1 2024.","Guides FY2024 R&D revenue ~$28M; first commercial product revenue expected 2H 2024 from UK burn device.","Awarded up to $150M US Government contract; initiated pivotal burn study for FDA submission."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249181,"accession_number":"0001213900-24-025128","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Spectral AI enters $30M standby equity purchase agreement with Yorkville, gets $5M note","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Company may sell up to $30M of common stock to Yorkville at 97% of lowest 3-day VWAP.","Yorkville provides up to $12.5M in convertible notes; first $5M tranche funded at $3.16/share fixed conversion.","Second $5M tranche due after SEC registration effectiveness or shareholder approval; third $2.5M 60 days later.","Convertible notes bear 0% interest (18% default), mature in 12 mo; variable conversion at 85% of VWAP, floor $0.47.","Commitment fees: $25k due diligence, 94,937 shares, plus $75k at six-month anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249180,"accession_number":"0001213900-24-018768","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-03-01T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints Peter Carlson as CEO; Fan steps down; reaffirms FY2024 revenue guidance ~$28M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Wensheng Fan resigned as CEO and director effective Feb 29, 2024; becomes Chief Innovation Strategist.","Peter Carlson appointed CEO; previously CFO. Vincent Capone assumes additional role of CFO and General Counsel.","Carlson receives $550K base salary, target bonus of $550K, and 150K RSUs; Capone gets $400K base and 150K RSUs.","Preliminary 2023 R&D revenue ~$18M; reaffirms FY2024 revenue guidance ~$28M reflecting first-quarter momentum.","Recent milestones include $149M BARDA award, UKCA authorization for DeepView AI-Burn, and FDA pivotal study enrollment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249179,"accession_number":"0001213900-24-016029","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-02-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI receives UKCA authorization for burn wound diagnosis; expects H2 2024 revenue","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["DeepView AI®-Burn obtained UKCA authorization for aiding burn wound diagnosis in the United Kingdom.","Company expects to deploy six devices in the UK for customer evaluation and start generating revenue in H2 2024.","This revenue adds to previously communicated $28 million revenue guidance for 2024.","Technology claims 92% accuracy in distinguishing healing vs. non-healing tissue vs. 50-75% for clinical observation.","UKCA authorization also opens expansion into regions like the Middle East that recognize the mark."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249178,"accession_number":"0001213900-24-012872","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-02-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI projects $28M 2024 revenue; $149M BARDA contract advances burn product","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["2023E revenue $17.4M; 2024E revenue guidance $28M, up 61% YoY.","Cash $7.4M, no long-term debt as of 9/30/2023; YTD 3Q23 net loss $17.3M.","BARDA Project BioShield contract total value $149M for burn wound assessment system.","Regulatory timeline: Burn UK approval 2024, DFU UK 2025; US burn 2026, US DFU 2026.","IP portfolio: 20 issued U.S./international patents, 34 pending applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249177,"accession_number":"0001213900-24-012284","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-02-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints founder Dr. J. Michael DiMaio to board; top shareholders extend lock-up 180 days","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. J. Michael DiMaio appointed to board effective Feb 7, 2024, filling vacancy left by Michael Murphy.","DiMaio is a founder, former CEO/Chairman (2011-2020), and a cardiac surgeon at Baylor Scott & White.","He has authored nearly 500 publications, led $150M+ in research funding, oversees 120+ clinical trials.","Two largest stockholders (DiMaio and Spangenberg) holding ~45% of shares extended lock-up for additional 180 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249176,"accession_number":"0001213900-24-009894","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-02-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Spectral AI updates on regulatory progress; expects UK DeepView revenue in H2 2024","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Submitted DeepView AI-Burn for UKCA marking; response expected 1H 2024; first UK revenue in H2 2024.","BARDA awarded $149M contract in Sept 2023, total BARDA awards over $250M; $55M for development through Q1 2026.","Initiated pivotal US burn study with 240 subjects; FDA submission for burn indication expected 1H 2025.","DFU validation study continues; FDA application for DFU indication anticipated in late 2024.","Closed $10M Committed Equity Facility with B. Riley; appointed Pete Carlson as CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249175,"accession_number":"0001213900-24-009311","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2024-02-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Michael Murphy resigns from Spectral AI board effective immediately","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Murphy resigned as director on January 30, 2024.","Resignation effective immediately; not due to any disagreement with the Company.","No replacement named; board size reduced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266677,"accession_number":"0001213900-23-098718","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-12-27T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Spectral AI enters $10M equity purchase agreement with B. Riley","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company can sell up to $10M of common stock to B. Riley at its discretion over 24 months.","Purchase price set at 3.5% discount to VWAP during purchase valuation period.","Issued 40,000 commitment shares valued at $2.50 each and agreed to $75K cash commitment fee.","Stock issuance capped at 19.99% of outstanding (3,249,360 shares) unless stockholder approval or price condition met.","B. Riley prohibited from short selling or hedging during agreement term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266676,"accession_number":"0001213900-23-097587","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-12-21T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI names Peter M. Carlson as CFO effective Jan 3, 2024; base $475K, bonus $475K, 150K RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Peter M. Carlson appointed CFO effective January 3, 2024; previously CFO at MiMedx Group (advanced wound care).","Annual base salary $475,000; eligible for target annual bonus of $475,000 based on Board-set milestones.","Granted 150,000 RSUs under 2022 LTIP, vesting over three years upon milestone achievement or time-based vesting.","Outgoing CFO Nils Windler will remain with the Company to support orderly transition and provide financial accounting support.","Carlson also served as COO at Brighthouse Financial and CAO at MetLife; CPA in NY and NC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266675,"accession_number":"0001213900-23-091017","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-11-29T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Spectral AI appoints largest shareholder Erich Spangenberg to Board and Executive Committee Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Erich Spangenberg appointed to Board and as Chairman of Executive Committee and Nominating & Corporate Governance Committee, effective immediately.","Spangenberg was the initial outside investor in 2011, served on board from 2012 to Oct 2022, and is the largest shareholder.","He brings 40 years of experience as entrepreneur, investor, and patent monetization leader; founder of Sauvegarder Investment Management.","Spangenberg cites Spectral AI's $251M non-dilutive US government funding and aims to maximize shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266674,"accession_number":"0001213900-23-086606","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-11-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Spectral AI Q3 revenue $3.4M, net loss $10.6M; affirms FY2023 guidance $17.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $3.4M (down 51% YoY); net loss $10.6M ($0.77/share) vs loss $0.4M in Q3 2022.","Adjusted EBITDA loss $3.9M vs $0.0M; non-recurring transaction costs $7.6M from Nasdaq listing.","Cash $7.3M, no long-term debt; reaffirms FY2023 revenue ~$17.4M and FY2024 ~$28.0M.","Received $149M U.S. government contract for DeepView System burn indication (total govt awards >$246M).","Plans to submit FDA/UKCA/CE mark apps for DFU and 3D wound measurement in 2024; burn in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":12769000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283923,"accession_number":"0001213900-23-080478","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-09-28T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Spectral AI subsidiary awarded up to $149M BARDA contract for DeepView burn imaging device","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total BARDA contract value up to $149M; initial award of $55M for DeepView clinical validation and FDA clearance.","Contract includes options up to $95M for additional development, procurement, and deployment.","Combined with prior awards, total BARDA support reaches nearly $251M; largest contract for SMD.","Up to 30 DeepView devices placed at burn centers for study; device has 92% diagnostic accuracy.","Contract supports U.S. government burn mass casualty preparedness; BARDA can terminate for convenience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283922,"accession_number":"0001213900-23-077038","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-09-15T23:59:59+00:00","items":["1.01","2.01","5.06","9.01","5.02","3.03","4.01","5.01","5.03","5.05","7.01"],"status":"ready","headline":"Spectral AI completes business combination with Spectral MD; begins trading on Nasdaq Sept 12","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Business Combination closed Sept 11; RCLF renamed Spectral AI, Inc.; common stock and warrants trade on Nasdaq as MDAI and MDAIW.","178,231 shares redeemed at ~$10.38/share; 15,688,268 shares outstanding post-close.","Pre-Closing Financing raised $3.351M from qualified institutional buyers and accredited investors.","Top shareholders: ELS 1960 Family 26.51%, John Michael DiMaio 15.79%, directors/officers 11.54%, Sponsor 5.8%.","Directors and executive officers named: Wensheng Fan, Michael P. Murphy, Jeffrey Thatcher, among others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283921,"accession_number":"0001213900-23-074550","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-09-07T23:59:59+00:00","items":["1.01","5.07","8.01","9.01"],"status":"ready","headline":"Rosecliff shareholders approve Spectral MD combination; 46% of public shares redeemed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved business combination: 6,341,342 for, 15,120 against, 6,000 abstain.","Public shareholders redeemed 211,136 Class A shares (46.02% of outstanding), leaving ~$2.57M in trust.","Lock-up agreement amended: period ends at $12.50 for 10 of 30 trading days or 180 days post-closing.","Business combination expected to close on or before September 11, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283920,"accession_number":"0001213900-23-060767","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-07-28T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Rosecliff Acquisition Corp I receives Nasdaq delisting notice for failure to meet minimum publicly held shares rule","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Rosecliff on July 24, 2023 that its securities will be delisted for non-compliance with minimum 500,000 publicly held shares requirement.","Company failed to regain compliance by extended deadline of July 21, 2023.","Company plans to request a hearing before Nasdaq Hearings Panel, which will stay delisting pending outcome.","No assurance that Panel will grant continued listing or that compliance can be evidenced within any extension period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303513,"accession_number":"0001213900-23-050967","cik":1833498,"company_name":"Spectral AI, Inc.","ticker":"MDAI","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Rosecliff Acquisition Corp I furnishes investor presentation for proposed Spectral MD business combination","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["DeepView System received FDA Breakthrough Device Designation for burn indication in 2018.","Spectral MD has secured over $130 million in U.S. government contracts for burn and DFU development.","Initial target markets (burn wounds + diabetic foot ulcers) estimated at ~$14.7 billion by 2028.","Proprietary AI database contains more than 263 billion clinically validated data points.","Regulatory submissions (FDA, CE, UKCA) expected to commence in 2023 based on positive study outcomes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":73513400.03797467,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-06-22T23:59:59+00:00|303513"}